Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
25.40
+0.14 (0.55%)
At close: Apr 26, 2024, 4:01 PM
25.44
+0.04 (0.16%)
After-hours: Apr 26, 2024, 7:59 PM EDT
Pfizer Revenue
In the year 2023, Pfizer had annual revenue of $58.50B, a decrease of -41.70%. Revenue in the quarter ending December 31, 2023 was $14.25B, a -41.34% decrease year-over-year.
Revenue (ttm)
$58.50B
Revenue Growth
-41.70%
P/S Ratio
2.45
Revenue / Employee
$664,727
Employees
88,000
Market Cap
143.43B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | 40.83B | -11.72B | -22.31% |
Dec 31, 2017 | 52.55B | -278.00M | -0.53% |
Dec 31, 2016 | 52.82B | 3.97B | 8.13% |
Dec 31, 2015 | 48.85B | -754.00M | -1.52% |
Dec 31, 2014 | 49.61B | -1.98B | -3.84% |
Dec 31, 2013 | 51.58B | -3.07B | -5.62% |
Dec 31, 2012 | 54.66B | -6.38B | -10.45% |
Dec 31, 2011 | 61.04B | -4.13B | -6.34% |
Dec 31, 2010 | 65.17B | 15.90B | 32.26% |
Dec 31, 2009 | 49.27B | 973.00M | 2.01% |
Dec 31, 2008 | 48.30B | -122.00M | -0.25% |
Dec 31, 2007 | 48.42B | 47.00M | 0.10% |
Dec 31, 2006 | 48.37B | 966.00M | 2.04% |
Dec 31, 2005 | 47.41B | -1.58B | -3.23% |
Dec 31, 2004 | 48.99B | 4.25B | 9.50% |
Dec 31, 2003 | 44.74B | 12.44B | 38.53% |
Dec 31, 2002 | 32.29B | 3.27B | 11.27% |
Dec 31, 2001 | 29.02B | 2.98B | 11.44% |
Dec 31, 2000 | 26.05B | -1.12B | -4.13% |
Dec 31, 1999 | 27.17B | 3.94B | 16.94% |
Dec 31, 1998 | 23.23B | 12.18B | 110.14% |
Dec 31, 1997 | 11.06B | 1.19B | 12.07% |
Dec 31, 1996 | 9.86B | -157.00M | -1.57% |
Dec 31, 1995 | 10.02B | 2.04B | 25.62% |
Dec 31, 1994 | 7.98B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Elevance Health | 171.75B |
Sanofi | 51.60B |
Novartis AG | 49.92B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
Amgen | 28.19B |
Danaher | 22.52B |
Stryker | 20.50B |
PFE News
- 2 days ago - What Factors Will Drive Pfizer's Q1 Performance? - Forbes
- 2 days ago - Pfizer Receives FDA Approval for Bleeding Disorder Treatment - Barrons
- 2 days ago - FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder - CNBC
- 2 days ago - US FDA approves Pfizer's gene therapy for rare bleeding disorder - Reuters
- 2 days ago - U.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B - Business Wire
- 3 days ago - GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology - Reuters
- 3 days ago - Pfizer Declares Second-Quarter 2024 Dividend - Business Wire
- 5 days ago - Pfizer vs Moderna battle over COVID vaccine patents begins in UK - Reuters